INS and type 2 diabetes mellitus: The expressions of neurotrophic receptor tyrosine kinases (NTRK1 and NTRK2) and neurotrophin 3 (NTF3), which regulate insulin-signaling pathway, were found to be down regulated in AD, while only NTRK2 was downregulated in T2DM.